The spontaneously hypertensive-rat as an animal model of ADHD: Evidence for impulsive and non-impulsive subpopulations

Neuroscience and Biobehavioral Reviews

Volumn 27, Issue 7, 2003, Pages 639-651

  Adriani, Walter ^a   Caprioli, Antonio ^b   Granstrem, Oleg ^c,d   Carli, Mirjana ^e   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Sigma Tau SpA   (Italy)

^c EMORY UNIVERSITY   (United States)

^d PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Attention deficit hyperactivity disorder; Cannabinoid; CB1 receptor; Impulsivity; Rat; Spontaneously hypertensive rat

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; NORADRENALIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ATTENTION DEFICIT DISORDER; CINGULATE GYRUS; CIRCADIAN RHYTHM; CONFERENCE PAPER; CONTROLLED STUDY; FRONTAL CORTEX; IMPULSIVENESS; INSTRUMENTAL CONDITIONING; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; RAT STRAIN; SPECIES COMPARISON; TASK PERFORMANCE;

EID: 0242659184     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2003.08.007     Document Type: Conference Paper

References (76)

1. Diagnostic and statistical manual of mental disorders. 4th ed. 1994;APA, Washington, DC.
2. Johansen E.B., Aase H., Meyer A., Sagvolden T. Attention deficit hyperactivity disorder (ADHD) behaviour explained by dysfunctioning reinforcement and extinction processes. Behav Brain Res. 130:2002;37-45.
3. Solanto M.V. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res. 130:2002;65-71.
4. Lahey B.B., Applegate B., McBurnett K., et al. The DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry. 151:1994;1673-1685.
5. Oades R.D. Dopamine may be 'hyper' with respect to noradrenaline metabolism, but 'hypo' with respect to serotonin metabolism, in children with attention-deficit hyperactivity disorder. Behav Brain Res. 130:2002;97-102.
6. Robbins T.W. The 5-choice serial reaction time task: behavioral pharmacology and functional neurochemistry. Psychopharmacology. 163:2002;362-380.
7. Carli M., Robbins T.W., Evenden J.L., Everitt B.J. Effects of lesions to ascending noradrenergic neurones on performance on a 5-choice serial reaction task in rats: implications for theories on dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res. 9:1983;361-380.
8. Oades R.D. Role of noradrenaline in tuning and dopamine in switching between signals in the CNS. Neurosci Biobehav Rev. 9:1985;365-391.
9. Halperin J.M., Newcorn J.H., Koda V.H., Pick L., McKay K.E., Knott P. Noradrenergic mechanisms in ADHD children with and without reading disabilities: a replication and extension. J Am Acad Child Adolesc Psychiatry. 36:1997;1391-1398.
10. Hanna G.L., Ornitz E.M., Hariharan M. Urinary cathecolamine excretion and behavioral differences in ADHD and normal boys. J Child Adolesc Psychopharmacol. 6:1996;63-73.
11. Linnoila M., Virkkunen M., Schenin M., Nutila A., Rimon R., Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci. 33:1983;2609-2614.
12. Thiebot M.H., Le Bihan C., Soubrié P., Simon P. Benzodiazepines reduce the tolerance to reward delay in rats. Psychopharmacology. 86:1985;147-152.
13. Soubrié P. Reconciling the role of central serotonin neurones in human and animal behavior. Behav Brain Sci. 9:1986;319-364.
14. Bizot J., Le Bihan C., Puech A.J., Hamon M., Thiebot M. Serotonin and tolerance to delay of reward in rats. Psychopharmacology. 146:1999;400-412.
15. Castellanos F.X., Elia J., Kruesi M.J.P., et al. Cerebrospinal fluid monoamine metabolites in boys with attention deficit hyperactivity disorder. Psychiatry Res. 52:1994;305-316.
16. Dalley J.W., Theobald D.E., Eagle D.M., Passetti F., Robbins T.W. Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology. 26:2002;716-728.
17. Puumala T., Sirvio J. Changes in activity of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task. Neuroscience. 83:1998;489-499.
18. Sonuga-Barke E.J.S., Taylor E., Sembi S., Smith J. Hyperactivity and delay aversion. I. The effect of delay on choice. J Child Psychol Psychiatry. 33:1992;387-398.
19. Solanto M.V., Abikoff H., Sonuga-Barke E., et al. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multi-modal treatment study of AD/HD. J Abnormal Child Psychol. 29:2001;215-228.
20. Evenden J.L., Ryan C.N. The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology. 128:1996;161-170.
21. Evenden J.L., Ryan C.N. The pharmacology of impulsive behaviour in rats. VI. The effects of ethanol and selective serotonergic drugs on response choice with varying delays of reinforcement. Psychopharmacology. 146:1999;413-421.
22. Adriani W., Della Seta D., Dessì-Fulgheri F., Farabollini F., Laviola G. Altered profiles of spontaneous novelty seeking, impulsive behaviour, and response to D-amphetamine in rats perinatally exposed to bisphenol-A. Environ Health Perspect. 111:2003;395-401.
23. Adriani W., Laviola G. Elevated levels of impulsivity and reduced place conditioning with D-amphetamine: two behavioral features of adolescence in mice. Behav Neurosci. 117:2003;695-703.
24. Wultz B., Sagvolden T. The hyperactive spontaneously hypertensive rat learns to sit still, but not to stop bursts of responses with short interresponse times. Behav Genet. 22:1992;415-433.
25. Sagvolden T., Metzger M.A., Sagvolden G. A frequent reward eliminates differences in activity between hyperkinetic rats and controls. Behav Neural Biol. 59:1993;225-229.
26. Sagvolden T., Pettersen M.B., Larsen M.C. Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains. Physiol Behav. 54:1993;1047-1055.
27. Mook D.M., Neuringer A. Different effects of amphetamine on reinforced variations versus repetitions in spontaneously hypertensive rats (SHR). Physiol Behav. 56:1994;939-944.
28. Berger D.F., Sagvolden T. Sex differences in operant discrimination behaviour in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res. 94:1998;73-82.
29. Aspide R., Fresiello A., de Filippis G., Carnevale U.A., Sadile A.G. Non-selective attention in a rat model of hyperactivity and attention deficit: subchronic methylphenydate and nitric oxide synthesis inhibitor treatment. Neurosci Biobehav Rev. 24:2000;59-71.
30. Aspide R., Carnevale U.A., Sergeant J.A., Sadile A.G. Non-selective attention and nitric oxide in putative animal models of attention-deficit hyperactivity disorder. Behav Brain Res. 95:1998;123-133.
31. Bull E., Reavill C., Hagan J.J., Overend P., Jones D.N. Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder: acquisition and performance of the DRL-60s test. Behav Brain Res. 109:2000;27-35.
32. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev. 24:2000;31-39.
33. Carey M.P., Diewald L.M., Esposito F.J., Pellicano M.P., Carnevale U.A., Sergeant J.A., Papa M., Sadile A.G. Differential distribution, affinity and plasticity of dopamine D1 and D2 receptors in the target sites of the mesolimbic system in an animal model of ADHD. Behav Brain Res. 94:1998;173-185.
34. Papa M., Sagvolden T., Sergeant J.A., Sadile A.G. Reduced CaMKII-positive neurones in the accumbens shell of an animal model of attention-deficit hyperactivity disorder. Neuroreport. 7:1996;3017-3020.
35. Papa M., Sergeant J.A., Sadile A.G. Differential expression of transcription factors in the accumbens of an animal model of ADHD. Neuroreport. 8:1997;1607-1612.
36. Papa M., Sergeant J.A., Sadile A.G. Reduced transduction mechanisms in the anterior accumbal interface of an animal model of attention-deficit hyperactivity disorder. Behav Brain Res. 94:1998;187-195.
37. Papa M., Diewald L., Carey M.P., Esposito F.J., Carnevale U.A., Sadile A.G. A rostrocaudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo- and a posterior hyperfunctioning meso-corticolimbic system. Behav Brain Res. 130:2002;171-179.
38. Russell V.A., de Villiers A.S., Sagvolden T., Lamm M.C., Taljaard J.J. Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder - the spontaneously hypertensive rat. Brain Res Bull. 53:2000;187-192.
39. Russell V.A. The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat as studied in vitro by the superfusion slice technique. Neurosci Biobehav Rev. 24:2000;133-136.
40. Viggiano D., Grammatikopoulos G., Sadile A.G. A morphometric evidence for a hyperfunctioning mesolimbic system in an animal model of ADHD. Behav Brain Res. 130:2002;181-189.
41. Russell V., de Villiers A., Sagvolden T., Lamm M., Taljaard J. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Brain Res. 676:1995;343-351.
42. Sadile A.G. Multiple evidence of a segmental defect in the anterior forebrain of an animal model of hyperactivity and attention deficit. Neurosci Biobehav Rev. 24:2000;161-169.
43. Papa M., Sellitti S., Sadile A.G. Remodeling of neural networks in the anterior forebrain of an animal model of hyperactivity and attention deficits as monitored by molecular imaging probes. Neurosci Biobehav Rev. 24:2000;149-156.
44. Russell V.A. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Behav Brain Res. 130:2002;191-196.
45. Spear L.P., Brake S.C. Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol. 16:1983;83-109.
46. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev. 24:2000;417-463.
47. Stamford J.A. Development and ageing of the rat nigrostriatal dopamine system studied with fast cyclic voltammetry. J Neurochem. 52:1989;1582-1589.
48. Teicher M.H., Andersen S.L., Hostetter J.C. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Dev Brain Res. 89:1995;167-172.
49. Stuss D.T., Eskes G.A., Foster J.K. Experimental neuropsychological studies of frontal lobe. Handbook of Neuropsychology. vol. 9:1994;. p. 149-85.
50. Hermann H., Marsicano G., Lutz B. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal sub-populations of the adult mouse forebrain. Neuroscience. 109:2002;451-460.
51. Darmani N.A., Pandya D.K. Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR141716A in naive mice. J Neural Transm. 107:2000;931-945.
52. Darmani N.A. Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice. Pharmacol Biochem Behav. 68:2001;311-317.
53. Cheer J.F., Cadogan A.K., Marsden C.A., Fone K.C., Kendall D.A. Modification of 5-HT2 receptor mediated behavior in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology. 38:1999;533-541.
54. Coccaro E.F., Kavoussi R.J., Sheline Y.I., Bermann M.E., Csernansky J.G. Impulsive aggression in personality disorder correlates with platelet 5-HT(2A) receptor binding. Neuropsychopharmacology. 16:1997;211-216.
55. Preuss U.W., Koller G., Bondy B., Bahlmann M., Soyka M. Impulsive traits and 5-HT(2A) receptor promoter polymorphism in alcohol dependents: possible association but no influence in personality disorders. Neuropsychobiology. 43:2001;186-191.
56. Lasley S.M., Michaelson I.A., Greenland R.D., McGinnis P.M. Simultaneous measurement of tyrosine, tryptophan and related monoamines for the determination of neurotransmitter turnover in discrete rat brain regions by liquid chromatography with electrochemical detection. J Chromatogr. 305:1984;27-42.
57. Dell'Omo G., Vannoni E., Vyssotski A.L., Di Bari M.A., Nonno R., Agrimi U., Lipp H.P. Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences. Eur J Neurosci. 16:2002;735-742.
58. Hooks M.S., Jones G.H., Juncos J.L., Neill D.B., Justice J.B. Individual differences in schedule-induced and conditioned behaviors. Behav Brain Res. 60:1994;199-209.
59. Piazza P.V., Maccari S., Deminiere J.M., Le Moal M., Mormede P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci USA. 88:1991;2088-2092.
60. Laviola G., Adriani W., Terranova M.L., Gerra G. Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci Biobehav Rev. 23:1999;993-1010.
61. Laviola G., Macri' S., Morley-Fletcher S., Adriani W. Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci Biobehav Rev. 27:2003;19-32.
62. Tirelli E., Laviola G., Adriani W. Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents. Neurosci Biobehav Rev. 27:2003;163-178.
63. Andersen S.L., Rutstein M., Benzo J.M., Hostetter J.C., Teicher M.H. Sex differences in dopamine receptor overproduction and elimination. Neuroreport. 8:1997;1495-1498.
64. Andersen S.L., Thompson A.T., Rutstein M., Hostetter J.C., Teicher M.H. Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse. 37:2000;167-169.
65. Beltramo M., Rodriguez de Fonseca F., Navarro M., Calignano A., Gorriti M.A., Grammatikopoulos G., Sadile A.G., Giuffrida A., Piomelli D. Reversal of dopamine D2 receptor responses by an anandamide transport inhibitor. J Neurosci. 20:2000;3401-3407.
66. Harrison A.A., Everitt B.J., Robbins T.W. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology. 133:1997;329-342.
67. Harrison A.A., Everitt B.J., Robbins T.W. Doubly dissociable effects of median- and dorsal-raphe lesions on the performance of the five-choice serial reaction time test of attention in rats. Behav Brain Res. 89:1997;135-149.
68. Wogar M.A., Bradshaw C.M., Szabadi E. Effect of lesions of the ascending 5-hydroxytryptaminergic pathways on choice between delayed reinforcers. Psychopharmacology. 111:1993;239-243.
69. Mobini S., Chiang T.J., Al-Ruwaitea A.S., Ho M.Y., Bradshaw C.M., Szabadi E. Effect of central 5-hydroxytryptamine depletion on inter-temporal choice: a quantitative analysis. Psychopharmacology. 149:2000;313-318.
70. Mobini S., Chiang T.J., Ho M.Y., Bradshaw C.M., Szabadi E. Effects of central 5-hydroxytryptamine depletion on the sensitivity to delayed and probabilistic reinforcement. Psychopharmacology. 152:2000;390-397.
71. Muir J.L., Everitt B.J., Robbins T.W. The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex. 6:1996;470-481.
72. Masserano J.M., Karoum F., Wyatt R.J. SR141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine. Behav Pharmacol. 10:1999;429-432.
73. Giuffrida A., Parsons L.H., Kerr T.M., Rodriguez de Fonseca F., Navarro M., Piomelli D. Dopamine activation of endogenous cannabinoid signalling in dorsal striatum. Nat Neurosci. 2:1999;358-363.
74. Ferrari F., Ottani A., Giuliani D. Influence of the cannabinoid agonist HU-210 on cocaine- and CQP-201-403-induced behavioral effects in rats. Life Sci. 65:1999;823-831.
75. Hayase T., Yamamoto Y., Yamamoto K. Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioral symptoms. J Pharm Pharmacol. 53:2001;1525-1532.
76. Hunziker M.H., Saldana R.L., Neuringer A. Behavioral variability in SHR and WKY rats as a function of rearing environment and reinforcement contingency. J Exp Anal Behav. 65:1996;129-144.